Release Date: 09/10/19 08:21 Summary: Preliminary September Quarter Production Results Price Sensitive: Yes Download Document 294.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%